Charles H. Fraga

2.9k total citations
37 papers, 2.3k citations indexed

About

Charles H. Fraga is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Charles H. Fraga has authored 37 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Surgery. Recurrent topics in Charles H. Fraga's work include Transplantation: Methods and Outcomes (6 papers), Cancer therapeutics and mechanisms (5 papers) and Vascular Anomalies and Treatments (5 papers). Charles H. Fraga is often cited by papers focused on Transplantation: Methods and Outcomes (6 papers), Cancer therapeutics and mechanisms (5 papers) and Vascular Anomalies and Treatments (5 papers). Charles H. Fraga collaborates with scholars based in United States, United Kingdom and Australia. Charles H. Fraga's co-authors include Clinton F. Stewart, James Dalton, Anna Marie Kenney, Michael S. Mulligan, Babu Naidu, Stéphane Angers, Michael D. Taylor, David W. Ellison, Africa Fernández-L and Paul A. Northcott and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Journal of Molecular Biology.

In The Last Decade

Charles H. Fraga

37 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles H. Fraga United States	21	1.1k	591	441	378	298	37	2.3k
Adriano Angelucci Italy	36	1.7k 1.5×	962 1.6×	227 0.5×	609 1.6×	262 0.9×	106	3.3k
Richard M. Lush United States	26	1.5k 1.4×	1.4k 2.4×	205 0.5×	451 1.2×	159 0.5×	78	3.3k
Xianxian Zheng United States	20	1.7k 1.5×	1.1k 1.9×	280 0.6×	958 2.5×	226 0.8×	30	3.4k
Risto Kerkelä Finland	31	2.0k 1.8×	1.1k 1.8×	247 0.6×	621 1.6×	190 0.6×	86	4.6k
Denis deBlois Canada	29	1.2k 1.1×	216 0.4×	565 1.3×	249 0.7×	176 0.6×	75	3.2k
Eleanor G. Zuhowski United States	26	1.0k 1.0×	718 1.2×	142 0.3×	383 1.0×	118 0.4×	50	2.2k
Françoise Bono France	29	1.3k 1.2×	380 0.6×	252 0.6×	108 0.3×	272 0.9×	65	2.7k
Georg Karpel‐Massler Germany	36	1.9k 1.7×	565 1.0×	881 2.0×	260 0.7×	195 0.7×	103	3.1k
Yi‐Yen Lee Taiwan	22	832 0.8×	624 1.1×	374 0.8×	184 0.5×	73 0.2×	70	1.8k

Countries citing papers authored by Charles H. Fraga

Since Specialization

Citations

This map shows the geographic impact of Charles H. Fraga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles H. Fraga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles H. Fraga more than expected).

Fields of papers citing papers by Charles H. Fraga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles H. Fraga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles H. Fraga. The network helps show where Charles H. Fraga may publish in the future.

Co-authorship network of co-authors of Charles H. Fraga

This figure shows the co-authorship network connecting the top 25 collaborators of Charles H. Fraga. A scholar is included among the top collaborators of Charles H. Fraga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles H. Fraga. Charles H. Fraga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tagen, Michael, Yanli Zhuang, Fan Zhang, et al.. (2010). P-Glycoprotein, but not Multidrug Resistance Protein 4, Plays a Role in the Systemic Clearance of Irinotecan and SN-38 in Mice. Drug Metabolism Letters. 4(4). 195–201. 29 indexed citations

Wilson, Matthew W., et al.. (2009). Expression of the Multi-Drug Resistance Proteins and the Pregnane X Receptor in Treated and Untreated Retinoblastoma. Current Eye Research. 34(5). 386–394. 9 indexed citations

Hubbard, Karen, Paula Schaiquevich, Feng Bai, et al.. (2009). Application of a highly specific and sensitive fluorescent HPLC method for topotecan lactone in whole blood. Biomedical Chromatography. 23(7). 707–713. 15 indexed citations

Narang, Vishal S., Charles H. Fraga, Narendra Kumar, et al.. (2008). Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. American Journal of Physiology-Cell Physiology. 295(2). C440–C450. 115 indexed citations

Shen, Jun, Charles H. Fraga, Christopher Calabrese, et al.. (2008). A modified surgical procedure for microdialysis probe implantation in the lateral ventricle of a FVB mouse. Journal of Pharmaceutical Sciences. 97(11). 5013–5023. 3 indexed citations

Dickson, Paxton V., John B. Hamner, Charles H. Fraga, et al.. (2007). Interferon β–mediated vessel stabilization improves delivery and efficacy of systemically administered topotecan in a murine neuroblastoma model. Journal of Pediatric Surgery. 42(1). 160–165. 15 indexed citations

Bai, Feng, et al.. (2007). Determination of Cloretazine™ (VNP40101M) and its active metabolite (VNP4090CE) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC–ESI-MS/MS). Journal of Chromatography B. 853(1-2). 97–104. 3 indexed citations

Wilson, Matthew W., Charles H. Fraga, Christine Fuller, et al.. (2006). Immunohistochemical Detection of Multidrug-Resistant Protein Expression in Retinoblastoma Treated by Primary Enucleation. Investigative Ophthalmology & Visual Science. 47(4). 1269–1269. 28 indexed citations

Fleming, Christopher D., Sompop Bencharit, Carol C. Edwards, et al.. (2005). Structural Insights into Drug Processing by Human Carboxylesterase 1: Tamoxifen, Mevastatin, and Inhibition by Benzil. Journal of Molecular Biology. 352(1). 165–177. 122 indexed citations

10.

Farivar, Alexander S., Steven Woolley, Babu Naidu, et al.. (2004). Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts. The Journal of Heart and Lung Transplantation. 23(8). 993–1002. 13 indexed citations

11.

Farivar, Alexander S., Steven Woolley, Charles H. Fraga, et al.. (2004). Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury. The Annals of Thoracic Surgery. 77(6). 1938–1943. 16 indexed citations

12.

Naidu, Babu, Steven Woolley, Alexander S. Farivar, et al.. (2004). Early tumor necrosis factor-α release from the pulmonary macrophage in lung ischemia-reperfusion injury. Journal of Thoracic and Cardiovascular Surgery. 127(5). 1502–1508. 56 indexed citations

13.

Mumtaz, Muhammad Ali, Charles H. Fraga, Shailesh Y. Desai, et al.. (2004). Increased expression of vascular endothelial growth factor messenger RNA in lungs of rats after cavopulmonary anastomosis. Journal of Thoracic and Cardiovascular Surgery. 129(1). 209–210. 5 indexed citations

14.

Krishnadasan, Baiya, Alexander S. Farivar, Babu Naidu, et al.. (2004). β-chemokine function in experimental lung ischemia-reperfusion injury. The Annals of Thoracic Surgery. 77(3). 1056–1062. 25 indexed citations

15.

Woolley, Steven, Alexander S. Farivar, Babu Naidu, et al.. (2004). Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion. Journal of Thoracic and Cardiovascular Surgery. 127(2). 376–384. 8 indexed citations

16.

Naidu, Babu, Alexander S. Farivar, Steven Woolley, et al.. (2003). Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis. Experimental and Molecular Pathology. 75(1). 12–17. 11 indexed citations

17.

Naidu, Babu, Charles H. Fraga, Andrew L. Salzman, et al.. (2003). Critical role of reactive nitrogen species in lung ischemia–reperfusion injury. The Journal of Heart and Lung Transplantation. 22(7). 784–793. 47 indexed citations

18.

Naidu, Babu, Steven Woolley, Alexander S. Farivar, et al.. (2003). Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion. Journal of Thoracic and Cardiovascular Surgery. 126(2). 482–489. 84 indexed citations

19.

Starnes, Sandra L., Brian W. Duncan, Geoffrey L. Rosenthal, et al.. (2001). Angiogenic proteins in the lungs of children after cavopulmonary anastomosis. Journal of Thoracic and Cardiovascular Surgery. 122(3). 518–523. 34 indexed citations

20.

Starnes, Sandra L., et al.. (2000). Pulmonary microvessel density is a marker of angiogenesis in children after cavopulmonary anastomosis. Journal of Thoracic and Cardiovascular Surgery. 120(5). 902–908. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact